0001179110-20-004927.txt : 20200417 0001179110-20-004927.hdr.sgml : 20200417 20200417160223 ACCESSION NUMBER: 0001179110-20-004927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200416 FILED AS OF DATE: 20200417 DATE AS OF CHANGE: 20200417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN MICHAEL CENTRAL INDEX KEY: 0001043027 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20799674 MAIL ADDRESS: STREET 1: 3 EAST 84 STREET CITY: NEW YORK STATE: NY ZIP: 10028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-04-16 0 0001477449 Teladoc Health, Inc. TDOC 0001043027 GOLDSTEIN MICHAEL C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 0 0 0 Common Stock 2020-04-16 4 M 0 13105 8.71 A 14023 D Common Stock 2020-04-16 4 M 0 1700 16.64 A 15723 D Common Stock 2020-04-16 4 S 0 918 165.93 D 14805 D Common Stock 2020-04-16 4 S 0 14805 169.13 D 0 D Stock Option (right to buy) 8.71 2020-04-16 4 M 0 13105 0.00 D 2025-02-25 Common Stock 13105 0 D Stock Option (right to buy) 16.64 2020-04-16 4 M 0 1700 0.00 D 2026-08-08 Common Stock 1700 8000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 29, 2020. Represents the weighted average price of transactions ranging from $166.00 to $171.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter. The option vested in full on May 24, 2017. /s/ Adam C. Vandervoort, attorney-in-fact 2020-04-17